Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects

Clinical trial NCT00481481 · COMPLETED

Trial details

NCT number: NCT00481481
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transplantation

Start date: 2007-04-01
Primary completion: 2009-04-01
Enrollment: 346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.